Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19.

Tamara CruzNúria MendozaGema María LledóLídia PereaNúria AlbacarAlvar AgustíJacobo SellaresOriol SibilaRosa Faner

Published in: ERJ open research (2023)

1 year after an acute COVID-19 episode, patients with either lung sequelae or long COVID show a stronger SARS-CoV-2-specific T-cell response than fully recovered individuals, suggesting persistent cell stimulation by residual viral reservoirs https://bit.ly/40bPZm7.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
single cell
liver failure
cell therapy
stem cells
extracorporeal membrane oxygenation
mechanical ventilation